Besides, a previous study from the Hasegawa group has reported that the ferroptosis inhibitor sulfasalazine, which targets SLC7A11, can increase DNA methylation on the mucin 1 gene (MUC1) promoter to regulate MUC1 gene transcription in triple-negative breast cancer [101]. This evidence concerns the gene MUC1 and triple-negative breast carcinoma.